EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis

Saad Ayyal Jabbar Al-Rikabi, Ali Etemadi iD, Maher Mohammed Morad, Azin Nowrouzi, Ghodarollah Shayriyar Panahi, Mozhgan Mondeali, Mahsa Toorani-Ghazvini, Ensieh Nasli-Esfahani, Farideh Razi, Fatemeh Bandarian

Endocrinology, Diabetes & Metabolism · 2024

DOI: 10.1002/edm2.484 ↗

At a glance

Journal article in Endocrinology, Diabetes & Metabolism, 2024. Written by Saad Ayyal Jabbar Al-Rikabi and 9 co-authors. Institution: Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Major MEDLINE topics: Prediabetic State, Metabolomics, Tandem Mass Spectrometry. Cited 1 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

This study investigates the metabolic differences between normal, prediabetic and diabetic patients with good and poor glycaemic control (GGC and PGC).

Design

In this study, 1102 individuals were included, and 50 metabolites were analysed using tandem mass spectrometry. The diabetes diagnosis and treatment standards of the American Diabetes Association (ADA) were used to classify patients.

Methods

The nearest neighbour method was used to match controls and cases in each group on the basis of age, sex and BMI. Factor analysis was used to reduce the number of variables and find influential underlying factors. Finally, Pearson's correlation coefficient was used to check the correlation between both glucose and HbAc1 as independent factors with binary classes.

Results

Amino acids such as glycine, serine and proline, and acylcarnitines (AcylCs) such as C16 and C18 showed significant differences between the prediabetes and normal groups. Additionally, several metabolites, including C0, C5, C8 and C16, showed significant differences between the diabetes and normal groups. Moreover, the study found that several metabolites significantly differed between the GGC and PGC diabetes groups, such as C2, C6, C10, C16 and C18. The correlation analysis revealed that glucose and HbA1c levels significantly correlated with several metabolites, including glycine, serine and C16, in both the prediabetes and diabetes groups. Additionally, the correlation analysis showed that HbA1c significantly correlated with several metabolites, such as C2, C5 and C18, in the controlled and uncontrolled diabetes groups.

Conclusions

These findings could help identify new biomarkers or underlying markers for the early detection and management of diabetes.

Subjects

MeSH terms (MEDLINE)

Prediabetic StateMetabolomicsTandem Mass SpectrometryHumansMaleFemaleMiddle AgedAdultGlycated HemoglobinBlood GlucoseDiabetes MellitusAgedBiomarkersDiabetes Mellitus, Type 2MetabolomeGlycemic ControlCarnitine

Author keywords

data analysisdiabetesmetabolomics tandem mass spectrometrynoncommunicable diseases

Substances

Glycated HemoglobinBlood GlucoseBiomarkersacylcarnitineCarnitine

Authors and institutions

  • Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Medical Biotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

ORCID profiles: Ali Etemadi

Cite

APA

Jabbar Al-Rikabi, S. A., Etemadi, A., Morad, M. M., Nowrouzi, A., Panahi, G. S., Mondeali, M., Toorani-Ghazvini, M., Nasli-Esfahani, E., Razi, F., & Bandarian, F. (2024). Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.484

Vancouver

Jabbar Al-Rikabi SA, Etemadi A, Morad MM, Nowrouzi A, Panahi GS, Mondeali M, et al. Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis. Endocrinology, Diabetes & Metabolism. 2024. doi:10.1002/edm2.484

BibTeX
@article{JabbarAlRikabi2024,
  author = {Jabbar Al-Rikabi, Saad Ayyal and Etemadi, Ali and Morad, Maher Mohammed and Nowrouzi, Azin and Panahi, Ghodarollah Shayriyar and Mondeali, Mozhgan and Toorani-Ghazvini, Mahsa and Nasli-Esfahani, Ensieh and Razi, Farideh and Bandarian, Fatemeh},
  title = {Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2024},
  doi = {10.1002/edm2.484}
}
Start for free →